The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

"Early warning signals" as testing demand rises for first time weeks

Thu, 18th Mar 2021 16:18

(Alliance News) - Community demand for coronavirus tests has increased by more than 9% in the last week, the first rise for five weeks, the Health & Safety Executive said.

HSE chief executive Paul Reid said the trend was an "early warning signal" that progress made in bringing down positive case numbers and hospital admissions is stalling.

Reid said there was "some concern" that the daily case numbers are no longer falling as they have been in recent weeks.

He told an HSE briefing on Thursday: "There are early warning signals for us that the brakes are being slightly put on in terms of improvements we've been making over the previous few weeks.

"Because the rate of decrease in hospitalisations for patients with Covid has slowed, particularly over the last few weeks, it's actually stalled.

"And the slowing in reduction of the hospitalised cases mirrors the slowing in reduction of the overall cases happening in the community."

He added: "Community testing demand has increased by over 9% in the past week, community demand for testing has increased for the first time in five weeks.

"That's just one of the early trends, early warning indicators I mentioned earlier on."

In terms of vaccinations however, Reid said the "glass is half full" despite problems with supply and the decision to pause administration of the AstraZeneca inoculation.

The European Medicines Agency is to decide on Thursday whether the AstraZeneca vaccine is safe after its use was paused by a number of European countries, including Ireland.

It followed reports by the Norwegian Medicines Agency of blood clots in a number of patients.

Reid said the decision to pause its use demonstrated the "huge emphasis that we will continuously put on safety of the population".

He added: "Just to reassure, we will respond quickly to whatever decision is recommended, and communicated onwards to us.

"Despite this disappointment we should, in my view, say the glass is half full.

"We have administered around 620,000 vaccinations, and we are witnessing, every day, the collapsing infection rates amongst residents in long-term care facilities, on health care workers and the oldest age groups in the population."

The HSE anticipates that between 70,000 and 75,000 vaccines will be administered next week in the over-70s population.

The health service has now carried out four million coronavirus tests and conducted one million close contact calls.

The seven days up to March 17 saw 3,646 new cases notified, an increase of 6% on the previous week.

Almost 46% of new cases over the past two weeks were among people aged 19 to 44 .

Some 26% of new cases in that period were among children aged 0 to 18 years, and about 8.6% were among people aged 65 years and over.

Reid said: "There are significant signs of stalling in the previously reported progress of cases.

"Numbers of new cases has slightly increased, the reductions in hospitalisations has certainly stalled last week. More positively, the numbers in ICU are reducing."

Over the last 14 days, of the 7,048 new cases notified between March 3 and 16, 6% of them (422) have been admitted to hospital.

Of those, 9% of them were in the age group 0 to 18, with no ICU admissions in that period.

Just over 19% were in the age group 19 to 34 with two ICU admissions.

Almost 33% were in the age group 35 to 64 with four ICU admissions, and around 29% were 65 and over, with seven ICU admissions.

Reid said: "Our hospitals still continue to have significant pressures in relation to Covid and management of Covid.

"We do hope that the progress we have seen in the past few weeks, picks up again in the coming couple of weeks."

On Wednesday, a further 17 deaths of people with coronavirus and another 557 confirmed cases of the virus were notified.

By James Ward, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
Today 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.